|
CAS-Nr. | 144701-48-4 |
Bezeichnung: | |
Englisch Name: | TELMISARTAN |
Synonyma: | TU-199;PRITOR;BIBR 277;MICARDIS;Telmisaran;TIMISHATAN;BIBR 277SE;21829-25-4;TELMISARTAN;TIMETAZIDINE |
CBNumber: | CB4266172 |
Summenformel: | C33H30N4O2 |
Molgewicht: | 514.63 |
MOL-Datei: | 144701-48-4.mol |
|
|
|
|
TELMISARTAN physikalisch-chemischer Eigenschaften |
|
|
storage temp. : |
Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
|
solubility : |
DMSO: >5 mg/mL at 60 °C
|
|
|
|
Wasserlöslichkeit: |
insoluble |
|
|
|
TELMISARTAN Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften White or off white crystalline powder |
|
|
Verwenden Telmisartan is an angiotensin II receptor antagonist. |
|
Verwenden anti-cancer agent |
|
Verwenden Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart |
|
R-Sätze Betriebsanweisung: R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut. |
|
S-Sätze Betriebsanweisung: S22:Staub nicht einatmen. S24/25:Berührung mit den Augen und der Haut vermeiden. S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen. S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren. |
|
|
TELMISARTAN Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 334)Lieferanten |
|
|
|
|
TU-199
TELMISARTAN
PRITOR
MICARDIS
BIBR 277
144701-48-4
4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID
4'-[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID
3-methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl sulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-
4'-[[1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]-methyl]-1,1'-biphenyl-2carboxylic acid,dimethylethyl ester
Telmisaran
Telmisartan99.5%
TelmisartanC33H30N402
C16H18N4O3S
C33H30N4O2
Micardis, Pritor, 4[(1,4Dimethyl-2propyl[2,6bi-H-benzimidazol]-1yl)methyl][1,1biphenyl]-2-carboxylic Acid,
TIMETAZIDINE
TIMISHATAN
4′-((2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl)methyl)biphenyl-2-carbonsure
1447014-48-4
Pharmaceutical material and intermeidates
Active Pharmaceutical Ingredients
C37H38N4O2
4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid
INTERMEDIATESOF
Antihypertensive
4'-[{1,4'-Dimethyl-2'-Propyl[2,6'-Bi-1H-Benzimiaszol]-1'yl}-Methyl}-1,1'-Biphenyl-2-Caroxylic Acid Dimethyl Ethyl Ester
Imidazoles
(intermediates of telmisartan)
4''-(1,7''-DIMETHYL-2''-PROPYL-1H-[2,5'']BIBENZOIMIDAZOLYL-3''-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID
4-chloromethyl-5-methyl-1,3-dioxol-2-tone
Telmisartan
4'-(1,7'-Dimethyl-2'-propyl-1H-
Hypertension
Intermediates & Fine Chemicals
Pharmaceuticals
API's
BIBR 277, 4μ[(1,4μ-Dimethyl-2μ-propyl[2,6μ-bi-1H-benzimidazol]-1μ-yl)methyl][1,1μ-biphenyl]-2-carboxylic acid
C20H24N2O5SD4
C33H27N4O2D3
4'-[[4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid
Telmisartan,4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid, BIBR 277
4'-[[1,4'-Dimethyl-2
Other Products
Telmisartan (150 mg)
2-(4-{[4-Methyl-6-(1-Methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]Methyl}phenyl)benzoic acid
TelMisartan (Micardis)
BIBR 277SE
TelMisartan API
Hypertension.
4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid
4'-((1,7'-DiMethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]iMidazol]-3'-yl)Methyl)-[1,1'-biphenyl]-2-carboxylic acid
4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-car
CARADRIN
21829-25-4
Telmisartan Synonyms 4'[(1,4'-Dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
|